kras mutation and glutathion KRAS-targeted therapies in cancer: novel approaches overcoming resistance Kras: structure and activation. (A)
Kras: structure and activation. (A) The Kras gene. Mutations in human Download Scientific Diagram KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site specific metastasis by stimulating glutathione synthesis: Cell Reports Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



